Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

$448.55 -0.82 (-0.18%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$448.80 +0.25 (+0.05%)

As of 05/22/2026 07:59 PM Eastern

Compare

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 23 Analyst Ratings

Sell
0

Hold
3

Buy
20

Based on 23 Wall Street analysts who have issued ratings for Thermo Fisher Scientific in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 3 have given a hold rating, 18 have given a buy rating, and 2 have given a strong buy rating for TMO.

Consensus Price Target

$616.10
37.35% Upside

According to the 23 analysts' twelve-month price targets for Thermo Fisher Scientific, the average price target is $616.10. The highest price target for TMO is $750.00, while the lowest price target for TMO is $490.00. The average price target represents a forecasted upside of 37.35% from the current price of $448.55.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for TMO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TMO Analyst Ratings Over Time

Type	Current Forecast 5/23/25 to 5/23/26	1 Month Ago 4/23/25 to 4/23/26	3 Months Ago 2/22/25 to 2/22/26	1 Year Ago 5/23/24 to 5/23/25
Strong Buy	2 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	18 Buy rating(s)	19 Buy rating(s)	18 Buy rating(s)	17 Buy rating(s)
Hold	3 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$616.10	$631.25	$633.68	$607.43
Forecasted Upside	37.35% Upside	35.19% Upside	24.02% Upside	54.35% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

TMO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TMO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Thermo Fisher Scientific Stock vs. The Competition

Type	Thermo Fisher Scientific	Medical Companies	Broader Market
Consensus Rating Score	2.96	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	37.35% Upside	1,714.95% Upside	15.10% Upside
News Sentiment Rating	Positive News See Recent TMO News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/14/2026	Royal Bank Of Canada 3 of 5 stars		Set Target	Sector Perform	$490.00	+9.35%
5/8/2026	Wells Fargo & Company 3 of 5 stars	Brandon Couillard 3 of 5 stars	Lower Target	Overweight	$675.00 ➝ $615.00	+33.17%
4/27/2026	Morgan Stanley 3 of 5 stars		Reiterated Rating	Overweight	$620.00	+31.53%
4/24/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong-Buy
4/24/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Arias Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$700.00 ➝ $600.00	+28.50%
4/24/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catherine Schulte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$653.00 ➝ $639.00	+36.85%
4/14/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$650.00 ➝ $625.00	+18.54%
4/8/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)
3/27/2026	DZ Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy	$610.00	+24.85%
1/30/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Leonard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral	$615.00	+6.13%
Get the Latest News and Ratings for TMO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.
1/30/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Donnelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$660.00 ➝ $685.00	+15.48%
1/30/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dan Brennan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$696.00 ➝ $683.00	+18.43%
1/5/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vijay Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$650.00	+7.53%
12/9/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Evie Koslosky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$685.00	+20.63%
12/7/2025	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Knight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Sector Weight ➝ Overweight	$750.00	+31.01%
12/1/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold ➝ Strong-Buy
10/29/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Toung Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$580.00 ➝ $610.00	+6.91%
10/23/2025	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
10/22/2025	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$545.00 ➝ $580.00	+2.04%
10/9/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$600.00 ➝ $650.00	+21.11%
10/8/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$580.00	+7.50%
8/18/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Larew Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform
7/24/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Cooper Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$525.00 ➝ $535.00	+11.59%
7/11/2025	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sung Ji Nam Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Sector Perform ➝ Sector Outperform	$590.00	+36.75%
1/10/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	E. Burstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$630.00	+15.60%
12/13/2024	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$675.00 ➝ $660.00	+26.05%
10/22/2024	Bernstein Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Market Perform	$565.00 ➝ $625.00	+6.30%
10/1/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Overweight	$680.00	+9.93%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:27 PM ET.

Should I Buy Thermo Fisher Scientific Stock? TMO Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 18, 2026. Please send any questions or comments about these Thermo Fisher Scientific pros and cons to contact@marketbeat.com.

Thermo Fisher Scientific
Bull Case

Here are some ways that investors could benefit from investing in Thermo Fisher Scientific Inc.:

The current stock price is around $615, reflecting a strong market position and investor confidence in the company's growth potential.
Recent upgrades from analysts, including a "strong-buy" rating from Jefferies Financial Group, indicate positive sentiment and potential for price appreciation.
Institutional ownership is high, with over 89% of shares held by institutional investors, suggesting strong backing and confidence from major financial entities.
Thermo Fisher Scientific Inc. has shown resilience in the market, with several large investors increasing their stakes, indicating a bullish outlook on the company's future performance.
The company has a diverse portfolio in medical research, which positions it well to capitalize on ongoing advancements in healthcare and biotechnology.

Thermo Fisher Scientific
Bear Case

Investors should be bearish about investing in Thermo Fisher Scientific Inc. for these reasons:

Recent reports indicate that some institutional investors, like Pinnacle Associates Ltd. and Applied Finance Capital Management LLC, have reduced their holdings, which may signal concerns about future performance.
Analysts have varied opinions on the stock, with some price targets being lowered, which could indicate potential volatility in the stock price.
The competitive landscape in the medical research sector is intense, and any significant advancements by competitors could impact Thermo Fisher Scientific Inc.'s market share.
Market conditions can be unpredictable, and economic downturns may affect the company's revenue, particularly if funding for research and development decreases.
Investors should be cautious of potential regulatory changes in the healthcare sector that could impact the company's operations and profitability.

TMO Forecast - Frequently Asked Questions

According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Thermo Fisher Scientific is $616.10, with a high forecast of $750.00 and a low forecast of $490.00.

23 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last twelve months. There are currently 3 hold ratings, 18 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" TMO shares.

According to analysts, Thermo Fisher Scientific's stock has a predicted upside of 37.35% based on their 12-month stock forecasts.

Over the previous 90 days, Thermo Fisher Scientific's stock had 2 upgrades by analysts.

Thermo Fisher Scientific has been rated by research analysts at Barclays, DZ Bank, Jefferies Financial Group, Morgan Stanley, Robert W. Baird, Royal Bank Of Canada, Stifel Nicolaus, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Thermo Fisher Scientific more than other "medical" companies. The consensus rating for Thermo Fisher Scientific is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how TMO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Thermo Fisher Scientific Recommendations

This page (NYSE:TMO) was last updated on 5/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target